Infection of Cronobacter sakazakii ST1 Producing SHV-12 in a Premature Infant Born from Triplet Pregnancy
Abstract
:1. Introduction
2. Case Presentation
3. Molecular Analysis of the C. sakazakii Isolate
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Yan, Q.Q.; Condell, O.; Power, K.; Butler, F.; Tall, B.D.; Fanning, S. Cronobacter species (formerly known as Enterobacter sakazakii) in powdered infant formula: A review of our current understanding of the biology of this bacterium. J. Appl. Microbiol. 2012, 113, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Jang, H.; Gopinath, G.R.; Eshwar, A.; Srikumar, S.; Nguyen, S.; Gangiredla, J.; Patel, I.R.; Finkelstein, S.B.; Negrete, F.; Woo, J.; et al. The secretion of toxins and other exoproteins of Cronobacter: Role in virulence, adaption, and persistence. Microorganisms 2020, 8, 229. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Strysko, J.; Cope, J.R.; Martin, H.; Tarr, C.; Hise, K.; Collier, S.; Bowen, A. Food safety and invasive Cronobacter infections during early infancy, 1961–2018. Emerg. Infect. Dis. 2020, 26, 857–865. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hunter, C.J.; Bean, J.F. Cronobacter: An emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis. J. Perinatol. 2013, 33, 581–585. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jason, J. The roles of epidemiologists, laboratorians, and public health agencies in preventing invasive Cronobacter infection. Front. Pediatr. 2015, 3, 110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kalyantanda, G.; Shumyak, L.; Archibald, L.K. Cronobacter species contamination of powdered infant formula and the implications for neonatal health. Front. Pediatr. 2015, 3, 56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McMullan, R.; Menon, V.; Beukers, A.G.; Jensen, S.O.; van Hal, S.J.; Davis, R. Cronobacter sakazakii infection from expressed breast milk, Australia. Emerg. Infect. Dis. 2018, 24, 393–394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Forsythe, S.J.; Dickins, B.; Jolley, K.A. Cronobacter, the emergent bacterial pathogen Enterobacter sakazakii comes of age; MLST and whole genome sequence analysis. BMC Genom. 2014, 15, 1121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Drieux, L.; Brossier, F.; Sougakoff, W.; Jarlier, V. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: Review and bench guide. Clin. Microbiol. Infect. 2008, 14 (Suppl. 1), 90–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Parra-Flores, J.; Holy, O.; Riffo, F.; Lepuschitz, S.; Maury-Sintjago, E.; Rodriguez-Fernandez, A.; Cruz-Cordova, A.; Xicohtencatl-Cortes, J.; Mancilla-Rojano, J.; Troncoso, M.; et al. Profiling the virulence and antibiotic resistance genes of Cronobacter sakazakii strains isolated from powdered and dairy formulas by whole-genome sequencing. Front. Microbiol. 2021, 12, 694922. [Google Scholar] [CrossRef] [PubMed]
- Liakopoulos, A.; van der Goot, J.; Bossers, A.; Betts, J.; Brouwer, M.S.M.; Kant, A.; Smith, H.; Ceccarelli, D.; Mevius, D. Genomic and functional characterisation of IncX3 plasmids encoding blaSHV-12 in Escherichia coli from human and animal origin. Sci. Rep. 2018, 8, 7674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Antibiotic | Minimal Inhibitory Concentration (MIC; mg/L) | Interpretation According to EUCAST Breakpoints |
---|---|---|
Ampicillin | >256 | Resistant |
Amoxicillin-clavulanic acid | 4 | Susceptible |
Ampicillin-sulbactam | 2 | Susceptible |
Piperacillin | 128 | Resistant |
Piperacillin-tazobactam | 2 | Susceptible |
Ceftazidime | 64 | Resistant |
Cefotaxime | 12 | Resistant |
Cefepime | 1 | Susceptible |
Aztreonam | 64 | Resistant |
Ertapenem | 0.032 | Susceptible |
Imipenem | 0.125 | Susceptible |
Meropenem | 0.032 | Susceptible |
Amikacin | 2 | Susceptible |
Gentamicin | 0.25 | Susceptible |
Tobramycin | 0.5 | Susceptible |
Ciprofloxacin | 0.25 | Susceptible |
Levofloxacin | 0.5 | Susceptible |
Tetracycline | 4 | Susceptible 1 |
Tigecycline | 0.25 | Susceptible |
Colistin | 0.25 | Susceptible |
Chloramphenicol | 8 | Susceptible |
Trimetoprim-sulfamethoxazole | 0.125 | Susceptible |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lachowska, M.; Izdebski, R.; Urbanowicz, P.; Żabicka, D.; Królak-Olejnik, B. Infection of Cronobacter sakazakii ST1 Producing SHV-12 in a Premature Infant Born from Triplet Pregnancy. Microorganisms 2021, 9, 1878. https://doi.org/10.3390/microorganisms9091878
Lachowska M, Izdebski R, Urbanowicz P, Żabicka D, Królak-Olejnik B. Infection of Cronobacter sakazakii ST1 Producing SHV-12 in a Premature Infant Born from Triplet Pregnancy. Microorganisms. 2021; 9(9):1878. https://doi.org/10.3390/microorganisms9091878
Chicago/Turabian StyleLachowska, Monika, Radosław Izdebski, Paweł Urbanowicz, Dorota Żabicka, and Barbara Królak-Olejnik. 2021. "Infection of Cronobacter sakazakii ST1 Producing SHV-12 in a Premature Infant Born from Triplet Pregnancy" Microorganisms 9, no. 9: 1878. https://doi.org/10.3390/microorganisms9091878
APA StyleLachowska, M., Izdebski, R., Urbanowicz, P., Żabicka, D., & Królak-Olejnik, B. (2021). Infection of Cronobacter sakazakii ST1 Producing SHV-12 in a Premature Infant Born from Triplet Pregnancy. Microorganisms, 9(9), 1878. https://doi.org/10.3390/microorganisms9091878